Cannes Lions

MIGRASPIRINA

L&A DIRECT MARKETING, Lisbon / BAYER / 2003

Presentation Image
1 of 0 items

Overview

Entries

Credits

OVERVIEW

Description

In order to arouse the doctors' interest for the information regarding Migraspirina, the option was to create a part that would be captivating for its looks, that would single out among all the communication received daily by doctors. After captivating the doctors' interest through the 'package', it was important to transmit the information in a nut-shell, so that all Migraspirina’s advantages were swiftly understood, leading the doctor to prescribe the medication.

Outcome

Migraspirina was launched, through pharmacies, in October 2002, but it was only officially launched to the consumer in January 2003.

In the pre-launch phase, when there was no disclosure to the consumer, Migraspirina conquered 5% of market share in the anti-migraine sector.

From January 2003, it increased to 20%, in February to 38%, and was sold out in both months.

Similar Campaigns

12 items

Claritin

MULLENLOWE BRASIL, Sao paulo

Claritin

2022, BAYER

(opens in a new tab)